Profile
| Role | Insider |
|---|---|
| Notability | 20/100 |
Board memberships
- Hyperliquid Strategies Inc
- Sonnet BioTherapeutics Holdings, Inc.
Updated Jul 16, 2026
Dyrness Albert D. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-12 | PURR | Hyperliquid Strategies Inc | A — Grant or award | 40.8K | $0.00 | |
| 2025-12-23 | PURR | Hyperliquid Strategies Inc | J — Other acquisition / disposition | 882 | — | |
| 2025-12-04 | SONN | Sonnet BioTherapeutics Holdings, Inc. | D — Derivative transaction | 4.5K | — | |
| 2025-07-11 | SONN | Sonnet BioTherapeutics Holdings, Inc. | A — Grant or award | 4.0K | — | |
| 2024-12-05 | SONN | Sonnet BioTherapeutics Holdings, Inc. | A — Grant or award | 373 | — |
Dyrness Albert D. is a corporate insider — currently tracked as Insider. InsiderAlpha tracks every SEC Form 4 filing in real time.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Dyrness Albert D. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.